Drug Type Small molecule drug |
Synonyms Norcalin, Tecalcet, Tecalcet hydrochloride (USAN) + [6] |
Target |
Mechanism CaSR modulators(Calcium sensing receptor modulators) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H23Cl2NO |
InChIKeyYJXUXANREVNZLH-PFEQFJNWSA-N |
CAS Registry177172-49-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D06020 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperparathyroidism | Phase 2 | US | - | |
Hyperparathyroidism | Phase 2 | JP | - | |
Hyperparathyroidism | Phase 2 | - | - | |
Hyperparathyroidism | Phase 2 | - | - | |
Hyperparathyroidism | Phase 2 | - | - | |
Osteoporosis, Postmenopausal | Phase 2 | - | - | |
Osteoporosis, Postmenopausal | Phase 2 | - | - | |
Osteoporosis, Postmenopausal | Phase 2 | - | - | |
Rheumatic Diseases | Phase 2 | US | - | |
Rheumatoid Arthritis | Phase 2 | - | - |
Not Applicable | 8 | R-568 (30 mg/kg/day) | uvwttubvhd(uufuixetvu) = pxawqfkoaj gioqcbceal (bhozfbazdu ) View more | Negative | 26 May 2017 |